SEC Form 4

Myomo Inc. (MYO) insider trading

In the 12 months to Oct 26, 2026, 3 MYO insiders reported open-market sales of $259.2K across 6 filings; 4 insiders bought $442.4K.

Latest filing Oct 15, 2026 · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales: $259.2K; 6 filings · 3 insiders
Open-market purchases: $442.4K; 9 filings

Who traded MYO, and when

Purchase
Sale

MYO daily closelast $1.22

Thomas F. Kirk · Director

$200.3K bought

Joseph M. Manko JR. · Director

$173.9K bought

Micah Mitchell · Chief Commercial Officer

$155.4K sold

Harry Kovelman · Chief Medical Officer

$82.7K sold

Heather C. Getz · Director

$64.9K bought

Milton Mayo Morris · Director

$21.2K sold

Thomas Aloysius Crowley JR. · Director

$3.2K bought

One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

15 filings in the last 12 months

Insider	Role	Sold	Bought	Filings	Pre-arranged (10b5-1)	Last filed
Thomas F. Kirk	Director	—	$200.3K	5	—	Jun 9, 2026
Joseph M. Manko JR.	Director	—	$173.9K	1	—	May 18, 2026
Micah Mitchell	Chief Commercial Officer	$155.4K	—	2	—	Jun 8, 2026
Harry Kovelman	Chief Medical Officer	$82.7K	—	3	—	Oct 15, 2026
Heather C. Getz	Director	—	$64.9K	2	—	Mar 17, 2026
Milton Mayo Morris	Director	$21.2K	—	1	—	Sep 4, 2026
Thomas Aloysius Crowley JR.	Director	—	$3.2K	1	—	Nov 21, 2025

Filed	Insider	Type	Shares	Avg price	Value	Held after
Oct 15, 2026 traded Sep 11, 2026	Harry Kovelman Chief Medical Officer	Sale	15,844	$1.27	$20.1K	89,889
Sep 4, 2026 traded Sep 2, 2026	Milton Mayo Morris Director	Sale	15,000	$1.41	$21.2K	208,391
Aug 24, 2026 traded Aug 20, 2026	Harry Kovelman Chief Medical Officer	Sale	17,500	$1.73	$30.3K	105,733
Jun 9, 2026 traded Jun 5, 2026	Thomas F. Kirk Director	Purchase	40,002	$1.27	$50.8K	693,865
Jun 8, 2026 traded May 14, 2026	Micah Mitchell Chief Commercial Officer	Sale	90,231	$0.86	$77.7K	109,478
Jun 1, 2026 traded May 28, 2026	Thomas F. Kirk Director	Purchase	25,000	$0.99	$24.8K	653,863
May 28, 2026 traded May 27, 2026	Harry Kovelman Chief Medical Officer	Sale	32,000	$1.01	$32.2K	108,618
May 18, 2026 traded May 15, 2026	Thomas F. Kirk Director	Purchase	75,006	$0.91	$68.2K	628,863
May 18, 2026 traded May 14, 2026	Joseph M. Manko JR. Director	Purchase	201,197	$0.86	$173.9K	2,309,775
May 15, 2026 traded May 14, 2025	Micah Mitchell Chief Commercial Officer	Sale	90,231	$0.86	$77.7K	109,478
Mar 17, 2026 traded Mar 16, 2026	Heather C. Getz Director	Purchase	20,000	$0.70	$14.0K	131,754
Mar 16, 2026 traded Mar 13, 2026	Thomas F. Kirk Director	Purchase	72,000	$0.71	$51.1K	553,857
Mar 12, 2026 traded Mar 12, 2026	Heather C. Getz Director	Purchase	70,000	$0.73	$51.0K	111,754
Nov 24, 2025 traded Nov 20, 2025	Thomas F. Kirk Director	Purchase	7,437	$0.72	$5.4K	481,857
Nov 21, 2025 traded Nov 18, 2025	Thomas Aloysius Crowley JR. Director	Purchase	4,385	$0.74	$3.2K	Multiple accounts

GET /stocks/filings/vX/form-4?tickers=MYO&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "MYO"
      ],
      "issuer_cik": "0001369290",
      "owner_cik": "0001853204",
      "accession_number": "0001193125-26-422930",
      "form_type": "4/A",
      "filing_date": "2026-10-15",
      "period_of_report": "2026-09-11",
      "issuer_name": "MYOMO, INC.",
      "issuer_trading_symbol": "MYO",
      "owner_name": "Kovelman Harry",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Medical Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-09-11",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 15844,
      "transaction_price_per_share": 1.2709,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 89889,
      "transaction_value": 20136.1396,
      "date_of_original_submission": "2026-09-14",
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Represents average sales price.  Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share.  Reporting party agrees to provide details of the transactions to the SEC upon request."
        }
      ],
      "remarks": "This Amendment is being filed to correct a transposition error on the number of shares sold and resulting change in shares beneficially owned following the transaciton on September 11, 2026."
    },
    {
      "tickers": [
        "MYO"
      ],
      "issuer_cik": "0001369290",
      "owner_cik": "0001853204",
      "accession_number": "0001193125-26-390646",
      "form_type": "4",
      "filing_date": "2026-09-14",
      "period_of_report": "2026-09-11",
      "issuer_name": "MYOMO, INC.",
      "issuer_trading_symbol": "MYO",
      "owner_name": "Kovelman Harry",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Medical Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-09-11",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 15488,
      "transaction_price_per_share": 1.2709,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 90245,
      "transaction_value": 19683.6992,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Represents average sales price.  Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share.  Reporting party agrees to provide details of the transactions to the SEC upon request."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.

Query this data with the API

Other insider activity (not market trades) · 35 records

Tax withholding12 records
Grants and awards23 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Filing date: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Counted once: When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

Frequently asked questions

Has Myomo Inc.'s CEO sold stock?

No. Paul R. Gudonis (CEO) made no open-market sales filed as CEO in the last 12 months.

How current is MYO’s insider data?

These are MYO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track MYO insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Claude ChatGPT

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MYO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.